STAASTAAR Surgical Company
Price
-20%1YEnd-of-day closes, not the intraday tick.
Cheap for a reason: check quality first
Quality shaky, a flag to check, undemanding price, growth steady, the market undecided.
STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. We are the leading manufacturer of phakic implantable lenses used worldwide in corrective or “refractive” surgery. We have been dedicated solely to ophthalmic surgery for over 40 years. Our goal is to position our refractive lenses throughout the world as primary and premium solutions for patients seeking visual freedom from wearing eyeglasses or contact lenses while achieving excellent visual acuity through refractive vision correction.
In the company’s own words · 10-K filed Mar 3, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
STAAR Surgical Company (STAA) reported revenue of $94M in Q2 2026 (quarter ended Jul 3, 2026), up 111% from the same quarter a year earlier. That came with a gross margin of 75% and net income of $8.1M (8.6% of revenue). For the full year FY2025, revenue was $239M (−24% year on year) and net income −$80M. Its largest region in Q2 2026 was Other Countries at $20M, 44% of the disclosed total, ahead of Japan at 25%. The next results filing is expected around Nov 4, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Oct 5, 2026On September 8, 2026, STAAR Surgical Company (the “Company”) announced that it appointed David Bailey as Chief Commercial Officer, effective that day Since 2010, Mr. Bailey has been the Founder and President of DB Consulting, a Switzerland-based strategic advisory firm providing advice to private equity firms and …Director or officer change · Form 8-K/A
- Sep 10, 2026On September 8, 2026, STAAR Surgical Company (the “Company”) announced that it appointed David Bailey as Chief Commercial Officer, effective that day Since 2010, Mr. Bailey has been the Founder and President of DB Consulting, a Switzerland-based strategic advisory firm providing advice to private equity firms and …Director or officer change · Form 8-K
- Aug 12, 2026STAAR Surgical Reports Second Quarter 2026 Results.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Jun 2026 · $44.7MThe company’s own SEC segment disclosure.
- Other Countries$19.7M44%
- Japan$11.1M25%
- China$9.5M21%
- South Korea$4.3M10%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Medical Instruments & Supplies
Ranks #9 of 21 by RyuScore